I collaborate with life science companies to craft creative IP strategies that protect their innovations and promote their business goals.
Ariana Harris is a seasoned patent attorney with more than ten years of experience counseling life sciences companies on the full spectrum of intellectual-property matters that drive scientific innovation from the laboratory to the marketplace. As a trusted strategic partner, Dr. Harris collaborates closely with scientists, in-house counsel, and executive leadership to align patent strategy with business objectives, secure pivotal exclusivity, and create leverage for licensing, partnership, and financing transactions.
Drawing on her doctoral training in molecular medicine from Boston University School of Medicine, Dr. Harris bridges complex biology with sophisticated legal strategy, enabling clients ranging from emerging biotechnology start-ups to mature pharmaceutical enterprises to secure, and monetize high-value patent assets.
Dr. Harris’s practice centers on building and managing global patent portfolios for cutting-edge modalities, including monoclonal antibodies, nucleic-acid therapeutics, cellular therapies, diagnostics, and immuno-oncology platforms. She routinely conducts patent-landscape and freedom-to-operate analyses that illuminate competitive positioning and inform research, development, and commercialization paths. Investors rely on her incisive due-diligence assessments to evaluate target IP strength, validity, and enforceability, while R&D teams depend on her guidance to design around third-party patents and mitigate infringement risk.
Her combination of scientific acuity, legal insight, and commercial perspective empowers clients to advance transformative therapies with confidence and speed in an increasingly crowded and competitive biopharmaceutical landscape.
